BioDelivery (BDSI) Files $40M Mixed Shelf
BioDelivery Sciences International, Inc. (Nasdaq: BDSI) filed a registration with the U.S. Securities and Exchange Commission to sell, from time to time, up to $40 million of Common Stock, Preferred Stock, Debt Securities, Warrants, Rights Units, or any combination thereof.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BioDelivery Sciences to Develop a Long-Acting Injectable Depot Formulation of Buprenorphine with Evonik for Use in Opioid Dependence and Pain
- TrueCar (TRUE) to Offer 1M Shares
- Western Gas Partners LP (WES) Prices 7.5M Common Offering at $70.85/Unit
Create E-mail Alert Related CategoriesEquity Offerings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!